Dec 19 (Reuters) - BioMarin Pharmaceutical (BMRN) said on Friday it would acquire Amicus Therapeutics (FOLD) for about $4.8 billion, expanding its presence in rare metabolic diseases.
The drugmaker will pay $14.50 per share for Amicus, a premium of 33.1% to the stock's last close. Shares of Amicus surged 30%, while BioMarin rose nearly 5% in premarket trading.
The deal strengthens BioMarin's portfolio with Amicus' approved genetic disorder treatments including Galafold, an oral drug for Fabry disease, which is caused by a faulty gene that leads to a buildup of fatty substances in cells.
Amicus also markets a combination therapy Pombiliti and Opfolda for Pompe disease, a genetic condition in which a complex sugar called glycogen builds up in the body's cells.
Amicus also has U.S. rights to DMX-200, a potential treatment of a type of kidney disease known as focal segmental glomerulosclerosis.
BioMarin intends to finance the deal through a combination of cash on hand and about $3.7 billion of non-convertible debt financing.
The company's total cash and investments at the end of September 30 were about $2 billion.
The acquisition, which is expected to close in the second quarter of 2026, will add revenue immediately after the transaction closes, BioMarin said.
The deal is also expected to add to adjusted profit in the first 12 months after close and be substantially accretive beginning in 2027, the company said.
(Reporting by Christy Santhosh and Sriparna Roy in Bengaluru; Editing by Leroy Leo and Maju Samuel)
LATEST POSTS
- 1
Mom warns of Christmas gift hazard as daughter recovers in hospital - 2Find the Effect of Web-based Entertainment on Society: Exploring the Computerized Scene
- 3Schools to start reopening after Nigeria mass abduction
- 4Blue Origin's next space tourism flight will break new ground for people with disabilities
- 5Shredded cheese recall: Multiple brands sold at Aldi, Target and Walmart affected over potential metal fragment contamination
- Instructions to Utilize Your Brain science Certification to Work on Corporate Culture
- The Effect of Online Organizations on Society: Beating the Difficulties
- The German series proving subtitles can be sexy — and wildly addictive
- My Excursion to Monetary Autonomy: Awesome ways to save cash
- Moon fever hits DC as Artemis 2 rocket 'candle' lights up Washington Monument just 1 month before launch (photos)
- The most effective method to Pick the Ideal Lab Precious stone Wedding band
- Manual for Big name Work out schedules
- IDF uncovers 7 km.-long Gaza terror tunnel where Hamas held Hadar Goldin
- The most effective method to Arrange a Higher Medical caretaker Pay During Your Next New employee screening
